Published in Prog Neurobiol on July 01, 1999
Reduced hippocampal volume among adolescents with alcohol use disorders without psychiatric comorbidity. Psychiatry Res (2005) 1.83
Glia pathology in the prefrontal cortex in alcohol dependence with and without depressive symptoms. Biol Psychiatry (2002) 1.22
A widespread distinct pattern of cerebral atrophy in patients with alcohol addiction revealed by voxel-based morphometry. J Neurol Neurosurg Psychiatry (2006) 1.19
Ethanol and cognition: indirect effects, neurotoxicity and neuroprotection: a review. Int J Environ Res Public Health (2010) 1.18
Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction. Ann N Y Acad Sci (2010) 1.17
Alcoholism and dampened temporal limbic activation to emotional faces. Alcohol Clin Exp Res (2009) 1.14
Chronic alcohol exposure induced gene expression changes in the zebrafish brain. Behav Brain Res (2010) 1.03
What does the mediodorsal thalamus do? Front Syst Neurosci (2013) 0.99
A novel role for glyceraldehyde-3-phosphate dehydrogenase and monoamine oxidase B cascade in ethanol-induced cellular damage. Biol Psychiatry (2009) 0.97
Alcohol induced depressive-like behavior is associated with a reduction in hippocampal BDNF. Pharmacol Biochem Behav (2011) 0.94
White matter volume in alcohol use disorders: a meta-analysis. Addict Biol (2012) 0.93
Increased white matter signal hyperintensities in long-term abstinent alcoholics compared with nonalcoholic controls. Alcohol Clin Exp Res (2008) 0.92
Alcohol and NMDA receptor: current research and future direction. Front Mol Neurosci (2013) 0.87
Comparison of prefrontal cell pathology between depression and alcohol dependence. J Psychiatr Res (2003) 0.87
Association of polymorphisms in RGS4 and expression of RGS transcripts in the brains of human alcoholics. Brain Res (2010) 0.84
S100B and homocysteine in the acute alcohol withdrawal syndrome. Eur Arch Psychiatry Clin Neurosci (2010) 0.83
Ethanol increases TIEG2-MAO B cell death cascade in the prefrontal cortex of ethanol-preferring rats. Neurotox Res (2010) 0.81
Alcohol dependence associated with increased utilitarian moral judgment: a case control study. PLoS One (2012) 0.81
Amygdalar neuronal plasticity and the interactions of alcohol, sex, and stress. Brain Struct Funct (2014) 0.81
Possible structural abnormality of the brainstem in unipolar depressive illness: a transcranial ultrasound and diffusion tensor magnetic resonance imaging study. J Neurol Neurosurg Psychiatry (2005) 0.81
Contributions of age and alcohol consumption to cerebellar integrity, gait and cognition in non-demented very old individuals. Eur Arch Psychiatry Clin Neurosci (2006) 0.81
Brain proton magnetic resonance spectroscopy of alcohol use disorders. Handb Clin Neurol (2014) 0.79
Cerebral A1 adenosine receptors (A1AR) in liver cirrhosis. Eur J Nucl Med Mol Imaging (2007) 0.79
The Neurocognitive Mechanisms of Decision-making, Impulse Control, and Loss of Willpower to Resist Drugs. Psychiatry (Edgmont) (2006) 0.79
Acamprosate modulates experimental autoimmune encephalomyelitis. Inflammopharmacology (2011) 0.78
Identifying gene networks underlying the neurobiology of ethanol and alcoholism. Alcohol Res (2012) 0.78
Associations of White Matter Microstructure with Clinical and Demographic Characteristics in Heavy Drinkers. PLoS One (2015) 0.77
Differential Contributions of Alcohol and Nicotine-Derived Nitrosamine Ketone (NNK) to White Matter Pathology in the Adolescent Rat Brain. Alcohol Alcohol (2015) 0.77
Ethanol down regulates the expression of myelin proteolipid protein in the rat hippocampus. Anat Cell Biol (2010) 0.77
White matter integrity is associated with alcohol cue reactivity in heavy drinkers. Brain Behav (2013) 0.77
Molecular and neurologic responses to chronic alcohol use. Handb Clin Neurol (2014) 0.76
Expression Profiling in Alcoholism Research. Alcohol Clin Exp Res (2005) 0.76
Association between alcohol and Alzheimer's disease. Exp Ther Med (2016) 0.75
The use of magnetic resonance spectroscopy and magnetic resonance imaging in alcohol research. Alcohol Res Health (2008) 0.75
Correlations between brain structures and study time at home in healthy children: a longitudinal analysis. Brain Behav (2014) 0.75
Baclofen to prevent agitation in alcohol-addicted patients in the ICU: study protocol for a randomised controlled trial. Trials (2016) 0.75
The effects of chronic smoking on the pathology of alcohol-related brain damage. Alcohol (2016) 0.75
Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res (1987) 2.80
The cerebral cortex is damaged in chronic alcoholics. Neuroscience (1997) 2.45
Cortical inflammation in Alzheimer disease but not dementia with Lewy bodies. Arch Neurol (2000) 2.08
Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology (2003) 1.98
Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain (2002) 1.85
Topography of brain atrophy during normal aging and Alzheimer's disease. Neurobiol Aging (1996) 1.75
Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry (1997) 1.67
Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus. J Invest Dermatol (2000) 1.59
Tracing the fate of limbal epithelial progenitor cells in the murine cornea. Stem Cells (2015) 1.45
An inflammatory review of Parkinson's disease. Prog Neurobiol (2002) 1.39
Nicotinamide reduces photodynamic therapy-induced immunosuppression in humans. Br J Dermatol (2012) 1.39
Interleukin-1beta but not tumor necrosis factor is involved in West Nile virus-induced Langerhans cell migration from the skin in C57BL/6 mice. J Invest Dermatol (2001) 1.36
Language-associated cortical regions are proportionally larger in the female brain. Arch Neurol (1997) 1.33
Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol (2001) 1.31
Cytoarchitecture of the human dorsal raphe nucleus. J Comp Neurol (1990) 1.25
Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma. J Invest Dermatol (1991) 1.22
Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. Brain (2000) 1.19
Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain (2005) 1.18
Anti-inflammatory drugs protect against Alzheimer disease at low doses. Arch Neurol (2000) 1.16
Regression in basal cell carcinoma: an immunohistochemical analysis. Br J Dermatol (1994) 1.15
Degeneration of the centré median-parafascicular complex in Parkinson's disease. Ann Neurol (2000) 1.14
Neuronal loss in functional zones of the cerebellum of chronic alcoholics with and without Wernicke's encephalopathy. Neuroscience (1999) 1.14
Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss. J Neurol Neurosurg Psychiatry (2002) 1.14
The comparative biology of neuromelanin and lipofuscin in the human brain. Cell Mol Life Sci (2008) 1.13
Skin cancer prevention: a possible role of 1,25dihydroxyvitamin D3 and its analogs. J Steroid Biochem Mol Biol (2005) 1.10
Variation in hippocampal neuron number with age and brain volume. Cereb Cortex (1998) 1.08
Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans. J Comp Neurol (1996) 1.08
Inflammatory S100A9 and S100A12 proteins in Alzheimer's disease. Neurobiol Aging (2005) 1.08
Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease. Exp Neurol (1997) 1.07
Regional brain atrophy in progressive supranuclear palsy and Lewy body disease. Ann Neurol (2000) 1.06
Squamous cell carcinoma growth in mice and in culture is regulated by c-Jun and its control of matrix metalloproteinase-2 and -9 expression. Oncogene (2006) 1.05
Cytokine profiles in spontaneously regressing basal cell carcinomas. Br J Dermatol (2000) 1.05
Induction of tolerance via skin depleted of Langerhans cells by a chemical carcinogen. Cell Immunol (1986) 1.05
Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study). J Neurol Neurosurg Psychiatry (2011) 1.04
Cytoarchitecture of serotonin-synthesizing neurons in the pontine tegmentum of the human brain. Synapse (1991) 1.04
Specific temporoparietal gyral atrophy reflects the pattern of language dissolution in Alzheimer's disease. Brain (1999) 1.02
Loss of vasopressin-immunoreactive neurons in alcoholics is dose-related and time-dependent. Neuroscience (1996) 1.01
Distribution, morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus. Neuroscience (1991) 1.01
Chronic alcohol consumption does not cause hippocampal neuron loss in humans. Hippocampus (1997) 1.01
Regression in skin tumours: a common phenomenon. Australas J Dermatol (1997) 1.01
Cortical degeneration associated with phonologic and semantic language impairments in AD. Neurology (2001) 1.00
Practical considerations for the use of the optical disector in estimating neuronal number. J Neurosci Methods (1994) 0.99
T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas. J Invest Dermatol (1997) 0.99
Photoprotection by 1alpha,25-dihydroxyvitamin D and analogs: further studies on mechanisms and implications for UV-damage. J Steroid Biochem Mol Biol (2010) 0.99
Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions? Prog Neurobiol (2010) 0.99
Differential effects of benzo[a]pyrene and dimethylbenz[a]-anthracene on Langerhans cell distribution and contact sensitization in murine epidermis. J Invest Dermatol (1989) 0.98
Phenotypic changes in Langerhans' cells after infection with arboviruses: a role in the immune response to epidermally acquired viral infection? J Virol (1996) 0.98
Carcinogen-induced depletion of cutaneous Langerhans cells. Br J Cancer (1985) 0.96
Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD4 T cells and dendritic cells. Clin Exp Dermatol (2004) 0.96
Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial. Br J Dermatol (2006) 0.95
Comparative anatomy of the ventromedial mesencephalic tegmentum in the rat, cat, monkey and human. J Comp Neurol (1986) 0.94
Localization of immunoreactivity for deleted in colorectal cancer (DCC), the receptor for the guidance factor netrin-1, in ventral tier dopamine projection pathways in adult rodents. Neuroscience (2005) 0.94
Clinical phenotypes in autopsy-confirmed Pick disease. Neurology (2011) 0.93
Ubiquitin-positive inclusions and progression of pathology in frontotemporal dementia and motor neurone disease identifies a group with mainly early pathology. Neuropathol Appl Neurobiol (2006) 0.93
Indomethacin inhibits the chemical carcinogen benzo(a)pyrene but not dimethylbenz(a)anthracene from altering Langerhans cell distribution and morphology. Br J Dermatol (1991) 0.93
White matter loss in healthy ageing: a postmortem analysis. Neurobiol Aging (2008) 0.92
Diffuse Lewy body disease: clinical features in nine cases without coexistent Alzheimer's disease. J Neurol Neurosurg Psychiatry (1996) 0.92
Practical measures to simplify the Braak tangle staging method for routine pathological screening. Acta Neuropathol (2000) 0.92
In vivo relevance for photoprotection by the vitamin D rapid response pathway. J Steroid Biochem Mol Biol (2007) 0.92
Langerhans cell migration is modulated by N-sulfated glucosamine moieties in heparin. Exp Dermatol (2000) 0.92
CD4 is expressed by epidermal Langerhans' cells predominantly as covalent dimers. Exp Dermatol (2003) 0.92
Evaluation of an ELISA system for determination of class-specific antibodies to native and denatured DNA in man. Ann Rheum Dis (1985) 0.92
Evidence that regression in keratoacanthoma is immunologically mediated: a comparison with squamous cell carcinoma. Br J Dermatol (1994) 0.91
Improved selectivity and sensitivity in the visualization of neurofibrillary tangles, plaques and neuropil threads. Neurodegeneration (1996) 0.91
Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans. Br J Dermatol (2002) 0.90
Broad-spectrum sunscreens provide greater protection against ultraviolet-radiation-induced suppression of contact hypersensitivity to a recall antigen in humans. J Invest Dermatol (1997) 0.89
BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours. Br J Dermatol (2011) 0.89
A 6-year study of cognition and spatial function in the demented and non-demented elderly: the Sydney Older Persons Study. Dement Geriatr Cogn Disord (2003) 0.89
Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. Brain (2002) 0.89
Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat. Behav Brain Res (2003) 0.89
Enhanced survival of skin grafts depleted of Langerhans' cells by treatment with dimethylbenzanthracene. Immunology (1987) 0.88
An action spectrum for ultraviolet radiation-induced immunosuppression in humans. Br J Dermatol (2011) 0.88
The nucleus basalis (Ch4) in the alcoholic Wernicke-Korsakoff syndrome: reduced cell number in both amnesic and non-amnesic patients. J Neurol Neurosurg Psychiatry (1997) 0.88
Langerhans cell presentation of sheep red blood cells induces antibody production. Immunol Cell Biol (1987) 0.88
Infiltration by inflammatory cells required for solar-simulated ultraviolet radiation enhancement of skin tumor growth. Cancer Immunol Immunother (2001) 0.87
Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease. Neuroscience (1997) 0.87
1,25-Dihydroxyvitamin D and three low-calcemic analogs decrease UV-induced DNA damage via the rapid response pathway. J Steroid Biochem Mol Biol (2004) 0.86
Similar early clinical presentations in familial and non-familial frontotemporal dementia. J Neurol Neurosurg Psychiatry (2004) 0.86
Anti-melanin antibodies are increased in sera in Parkinson's disease. Exp Neurol (2009) 0.86
Substance P-containing neurons in the mesopontine tegmentum are severely affected in Parkinson's disease. Brain (1991) 0.86
Calbindin D28k-containing neurons are restricted to the medial substantia nigra in humans. Neuroscience (1995) 0.86
The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy. Mov Disord (1999) 0.86
Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma. Cancer Immunol Immunother (2008) 0.86
Quantitative analysis of the variability of substantia nigra pigmented cell clusters in the human. Neuroscience (1995) 0.86
A novel technique for the examination of skin biopsies by laser capture microdissection. J Cutan Pathol (2003) 0.86
Relationship between DNA fragmentation, morphological changes and neuronal loss in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol (2001) 0.85
Quantitative assessment of Langerhans cells in actinic keratosis, Bowen's disease, keratoacanthoma, squamous cell carcinoma and basal cell carcinoma. Pathology (1986) 0.85
Simplified neuropathological diagnosis of dementia with Lewy bodies. Neuropathol Appl Neurobiol (1998) 0.85
CD4+ T lymphocyte infiltration correlates with regression of a UV-induced squamous cell carcinoma. J Dermatol Sci (1995) 0.85
Progressor but not regressor skin tumours inhibit Langerhans' cell migration from epidermis to local lymph nodes. Immunology (1999) 0.85
Neurofibrillary degeneration and cell loss in the nucleus basalis in comparison to cortical Alzheimer pathology. Neurobiol Aging (1998) 0.84
Evidence for specific phases in the development of human neuromelanin. Neurobiol Aging (2006) 0.84
Rostrocaudal differences in morphology and neurotransmitter content of cells in the subretrofacial vasomotor nucleus. J Auton Nerv Syst (1992) 0.84
Anatomical and immunohistochemical identification of catecholaminergic neurones in brain slice preparations used in electrophysiology. J Neurosci Methods (1996) 0.84
Neurofibrillary tangles in chronic alcoholics. Neuropathol Appl Neurobiol (1995) 0.84
New methodology for assessment of the Langerhans cell network. J Pathol (1986) 0.84
Comparison of the number of vasopressin-producing hypothalamic neurons in rats and humans. J Neuroendocrinol (1995) 0.84
Quantification of cortical atrophy in a case of progressive fluent aphasia. Brain (1996) 0.84
Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated with very early onset Alzheimer's disease. Neuroreport (1998) 0.83